Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Aptuit

Aptuit is a pharmaceutical services company that delivers early to mid-phase drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Aptuit
Via Alessandro Fleming 4, 37135 Verona (VR), Italy
+39 045 8218111
Contact Aptuit
Website

 Latest Content from PMHub 

LUCID GROUP PARTNERS WITH NEW INVESTOR ICG

Press Releases | March 10, 2021 | Lucid Group Communications Limited

Lucid Group has secured a new investment from Intermediate Capital Group (ICG) to support its continued ambition to build a global business that delivers life transforming value for everyone.Founded in...

WHITE PAPER: What’s missing in women’s health?

White Papers and Resources | March 9, 2021 | IGNIFI

In July of last year, amidst stories in the press around HRT and contraception shortages, endometriosis going undiagnosed and unsafe medical devices being offered to women, we wrote an edition...

IWD2021: #ChooseToChallenge Interview with Dennis O’Brien, Lucid Group CEO

Press Releases | March 8, 2021 | Lucid Group Communications Limited

Hey Dennis, what does this year’s IWD slogan, #ChooseToChallenge mean to you?I love it. It’s inspirational and action-oriented. It’s clear we need to change many things in our society, inequality...

Gene Editing and Precision Medicine: The Future of Healthcare?

Videos and Podcasts | March 4, 2021 | Impetus Digital

Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,...

CRM Design and Optimization for Life Science Organizations

Videos and Podcasts | March 4, 2021 | Impetus Digital

John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical...

Andi Goes – the children’s book that helps detect early signs of dyslexia

Press Releases | March 3, 2021 | Havas Lynx

Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...

The imperfect art of sustainable communications

Press Releases | March 2, 2021 | 11 London

Scanning the papers this last week, we’ve seen a welcome departure from wall-to-wall gloom –and very real signs of ‘Reasons To Be Cheerful’.The economy, we’re told, might not be such...

Good design saves lives

White Papers and Resources | March 2, 2021 | Page & Page Health

Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics

Press Releases | March 1, 2021 | Onyx Health

Leading biotechnology company NovaBiotics Ltd have secured a major licensing deal for their fungal nail treatment

Rare Disease Day in a COVID-19 environment

Press Releases | February 28, 2021 | Lucid Group Communications Limited

For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your...